Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TN › Knoxville › NPI 1538164090
Agency

University Health System, INC.

University Health System, INC. was paid $13.83M by Medicaid between Jan 2018 and Dec 2024, across 202 billing codes. Its largest line is 99284, emergency room visit (serious) — 48% of everything it billed.

33Billing provider infoUNIVERSITY HEALTH SYSTEM, INC.
KNOXVILLE, TN 37920
33aNPI1538164090assigned 06/20/2005
33bProvider typeHome Health Agency
28Total paid$13.83M
24GClaims472,187
24DCodes billed202
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Home Health Agency providers in Tennessee

Rank by total paid#9 of 100
Median peer was paid$682K
This provider vs. median20×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201866,779$1.50M
201981,286$2.37M
202074,665$2.40M
202171,547$2.08M
202267,288$2.02M
202372,628$2.19M
2024incomplete37,994$1.28M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 48% 47,802 40,928 $6.61M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 11% 17,700 15,640 $1.58M
99282 Emergency department visit for the evaluation and management, low to moderate severity 5.8% 13,671 12,556 $806K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 4.7% 11,300 9,740 $646K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 4.1% 6,391 3,051 $572K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 3.9% 105,947 80,062 $535K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 3.0% 7,988 7,258 $415K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 3.0% 10,434 3,274 $412K
59025 Fetal non-stress test 2.1% 5,385 4,682 $291K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1.7% 896 786 $233K
80053 Comprehensive metabolic panel 1.4% 75,578 56,866 $196K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.0% 966 836 $144K
190 more codes
77067 Screening mammography, bilateral, including computer-aided detection <1% 2,694 $114K
84484 <1% 6,358 $105K
96361 Intravenous infusion, hydration; each additional hour <1% 2,967 $88K
71045 Radiologic examination, chest; single view <1% 4,089 $83K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 1,761 $62K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 352 $55K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 10,811 $54K
71046 Radiologic examination, chest; 2 views <1% 2,345 $53K
70450 Computed tomography, head or brain; without contrast material <1% 489 $49K
99285 Emergency room visit (most serious) <1% 151 $46K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 294 $42K
96375 Therapeutic injection; each additional sequential IV push <1% 2,004 $40K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 554 $31K
77063 Screening digital breast tomosynthesis, bilateral <1% 2,501 $28K
83690 <1% 5,503 $26K
96367 <1% 924 $24K
77336 <1% 530 $23K
87088 <1% 3,257 $22K
80048 Basic metabolic panel (calcium, ionized) <1% 7,283 $22K
93925 <1% 402 $20K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 58 $20K
81001 <1% 25,498 $20K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,447 $18K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 3,042 $16K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 35 $14K
83735 <1% 5,065 $13K
0001A <1% 432 $13K
84702 <1% 775 $12K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 132 $12K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 306 $11K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 471 $11K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 59 $11K
80047 <1% 3,268 $10K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 5,888 $10K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 661 $9K
82728 <1% 2,299 $9K
11043 <1% 145 $9K
J1453 Injection, fosaprepitant, 1 mg <1% 40 $9K
0002A <1% 275 $8K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 54 $8K
J2469 Injection, palonosetron hcl, 25 mcg <1% 136 $8K
84238 <1% 261 $7K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 749 $7K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 242 $7K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 60 $7K
71275 Computed tomographic angiography, chest, with contrast material <1% 32 $7K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 72 $6K
83550 <1% 2,236 $6K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 13 $6K
36415 Collection of venous blood by venipuncture <1% 4,627 $6K
81000 <1% 3,018 $5K
93970 <1% 33 $4K
82668 <1% 441 $3K
85652 <1% 1,731 $3K
80061 Lipid panel <1% 30 $3K
36591 <1% 111 $3K
93922 <1% 389 $3K
82550 <1% 1,493 $3K
84443 Thyroid stimulating hormone (TSH) <1% 1,066 $3K
72125 Computed tomography, cervical spine; without contrast material <1% 26 $2K
11045 <1% 194 $2K
82607 <1% 520 $2K
83010 <1% 565 $2K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 34 $2K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,110 $2K
83605 <1% 223 $2K
86900 <1% 269 $2K
77300 <1% 29 $2K
77386 <1% 131 $2K
82746 <1% 425 $2K
86850 <1% 284 $2K
97161 <1% 12 $2K
82024 <1% 285 $1K
86140 <1% 2,306 $1K
73120 <1% 145 $1K
80197 <1% 1,311 $1K
83880 <1% 114 $1K
85610 <1% 494 $1K
82570 <1% 1,053 $1K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 35 $1K
94762 <1% 27 $1K
83615 <1% 1,884 $1K
93017 <1% 95 $1K
93880 <1% 62 $1K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 33 $1K
85045 <1% 686 $977.95
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 32 $969.91
94761 <1% 203 $964.41
84439 <1% 694 $946.43
76830 Ultrasound, transvaginal <1% 13 $927.99
87040 <1% 45 $917.27
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 6,538 $830.29
81025 <1% 267 $796.66
76000 <1% 79 $794.22
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 131 $779.74
J1650 Injection, enoxaparin sodium, 10 mg <1% 94 $718.70
71250 <1% 30 $704.10
82533 <1% 385 $703.09
86901 <1% 269 $687.41
84550 <1% 1,588 $631.00
87400 <1% 117 $624.37
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 59 $576.16
87799 <1% 78 $548.50
84100 <1% 1,602 $536.91
J1626 Injection, granisetron hydrochloride, 100 mcg <1% 123 $522.77
87186 <1% 120 $511.41
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 15 $480.15
72202 <1% 16 $465.71
J2785 Injection, regadenoson, 0.1 mg <1% 36 $450.36
96523 <1% 27 $450.26
70355 <1% 29 $444.96
90715 <1% 18 $378.25
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,250 $374.48
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,337 $362.75
87070 <1% 378 $356.72
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 26 $355.00
87081 <1% 92 $345.81
73562 <1% 29 $319.28
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 53 $283.23
J2060 Injection, lorazepam, 2 mg <1% 43 $274.43
82962 <1% 99 $265.68
92567 <1% 49 $258.17
84156 <1% 1,326 $249.98
82565 <1% 1,657 $246.10
94010 <1% 13 $234.07
86160 <1% 14 $212.52
64615 <1% 17 $211.56
80076 <1% 316 $203.00
85027 <1% 204 $179.70
76642 <1% 15 $172.87
84450 <1% 60 $168.41
84460 <1% 58 $168.41
94729 <1% 15 $159.60
82140 <1% 29 $159.03
94726 <1% 15 $145.86
82465 <1% 1,424 $144.29
J2270 Injection, morphine sulfate, up to 10 mg <1% 74 $143.85
85730 <1% 37 $142.00
73130 <1% 27 $138.60
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 16 $135.53
99213 Doctor's office visit, returning patient (routine) <1% 18 $135.00
82105 <1% 178 $134.68
72100 <1% 15 $115.32
86708 <1% 72 $114.68
87497 <1% 14 $114.08
83036 Hemoglobin; glycosylated (A1C) <1% 17 $112.08
J1170 Injection, hydromorphone, up to 4 mg <1% 106 $88.46
86706 <1% 81 $86.26
80074 <1% 112 $79.55
85379 <1% 16 $69.80
86255 <1% 30 $66.84
83540 <1% 275 $60.33
86707 <1% 26 $55.42
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 17 $55.08
G0378 Hospital observation service, per hour <1% 181 $53.40
J2550 Injection, promethazine hcl, up to 50 mg <1% 74 $48.09
84520 <1% 34 $46.76
73610 <1% 17 $46.20
73630 <1% 13 $46.20
86304 <1% 14 $45.50
86480 <1% 89 $44.62
87522 Neg quan hep c or qual rna <1% 16 $30.84
87077 <1% 17 $27.34
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 13 $26.01
86235 <1% 15 $19.36
87350 <1% 17 $12.45
87340 <1% 27 $11.16
86225 <1% 12 $9.90
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 1,793 $8.70
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 663 $7.87
86705 <1% 13 $4.24
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 37 $3.60
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,845 $3.15
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 1,046 $1.02
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 0% 251 $0.00
85007 0% 312 $0.00
Q9957 Injection, perflutren lipid microspheres, per ml 0% 141 $0.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 0% 34 $0.00
Q0243 Injection, casirivimab and imdevimab, 2400 mg 0% 36 $0.00
J1644 Injection, heparin sodium, per 1000 units 0% 58 $0.00
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) 0% 153 $0.00
C1769 Guide wire 0% 948 $0.00
J0690 Injection, cefazolin sodium, 500 mg 0% 1,287 $0.00
88342 0% 229 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 0% 34 $0.00
82378 0% 18 $0.00
J0696 Injection, ceftriaxone sodium, per 250 mg 0% 75 $0.00
C1889 Implantable/insertable device, not otherwise classified 0% 15 $0.00
88307 0% 19 $0.00
J2370 Injection, phenylephrine hcl, up to 1 ml 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLANDSMAN, JOSEPH (CEO)